The global epidemic of SARS-CoV-2 variants and their mutational immune escape

被引:82
|
作者
Tian, Dandan [1 ]
Sun, YanHong [1 ]
Zhou, JianMing [1 ]
Ye, Qing [1 ]
机构
[1] Zhejiang Univ, Natl Clin Res Ctr Child Hlth, Natl Childrens Reg Med Ctr, Dept Clin Lab,Childrens Hosp,Sch Med, Hangzhou, Peoples R China
关键词
COVID-19; immune escape; mutations; SARS-CoV-2; variants; ACUTE RESPIRATORY SYNDROME; VIRAL INFECTIVITY; SPIKE; CORONAVIRUS; VACCINE; ACE2; NEUTRALIZATION; RECOMBINATION; REPLICATION; MECHANISMS;
D O I
10.1002/jmv.27376
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During the COVID-19 pandemic, genetic variants of SARS-CoV-2 have been emerging and spreading around the world. Several SARS-CoV-2 endemic variants were found in United Kingdom, South Africa, Japan, and India between 2020 and April 2021. Studies have shown that many SARS-CoV-2 variants are more infectious than early wild strain and produce immune escape. These SARS-CoV-2 variants have brought new challenges to the prevention and control of COVID-19. This review summarizes and analyzes the biological characteristics of different amino acid mutations and the epidemic characteristics and immune escape of different SARS-CoV-2 variants. We hope to provide scientific reference for the monitoring, prevention, and control measures of new SARS-CoV-2 variants and the development strategy of the second-generation vaccine.
引用
收藏
页码:847 / 857
页数:11
相关论文
共 50 条
  • [1] The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
    Tian, Dandan
    Sun, Yanhong
    Zhou, Jianming
    Ye, Qing
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [2] Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
    Lou, Fuxing
    Li, Maochen
    Pang, Zehan
    Jiang, Lin
    Guan, Lin
    Tian, Lili
    Hu, Jiaming
    Fan, Junfen
    Fan, Huahao
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [3] SARS-CoV-2 variants, immune escape, and countermeasures
    Zhang, Yi
    Zhang, Haocheng
    Zhang, Wenhong
    FRONTIERS OF MEDICINE, 2022, 16 (02) : 196 - 207
  • [4] SARS-CoV-2 variants, immune escape, and countermeasures
    Zhang Yi
    Zhang Haocheng
    Zhang Wenhong
    Frontiers of Medicine, 2022, 16 (02) : 196 - 207
  • [5] SARS-CoV-2 variants, immune escape, and countermeasures
    Yi Zhang
    Haocheng Zhang
    Wenhong Zhang
    Frontiers of Medicine, 2022, 16 : 196 - 207
  • [6] Receptor binding, immune escape, and protein stability direct the natural selection of SARS-CoV-2 variants
    Upadhyay, Vaibhav
    Lucas, Alexandra
    Panja, Sudipta
    Miyauchi, Ryuki
    Mallela, Krishna M. G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 297 (04)
  • [7] SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021
    Alkhatib, Mohammad
    Svicher, Valentina
    Salpini, Romina
    Ambrosio, Francesca Alessandra
    Bellocchi, Maria Concetta
    Carioti, Luca
    Piermatteo, Lorenzo
    Scutari, Rossana
    Costa, Giosue
    Artese, Anna
    Alcaro, Stefano
    Shafer, Robert
    Ceccherini-Silberstein, Francesca
    MICROBIOLOGY SPECTRUM, 2021, 9 (03):
  • [8] SARS-CoV-2 Mutations and their Viral Variants
    Cosar, Begum
    Karagulleoglu, Zeynep Yagmur
    Unal, Sinan
    Ince, Ahmet Turan
    Uncuoglu, Dilruba Beyza
    Tuncer, Gizem
    Kilinc, Bugrahan Regaip
    Ozkan, Yunus Emre
    Ozkoc, Hikmet Ceyda
    Demir, Ibrahim Naki
    Eker, Ali
    Karagoz, Feyzanur
    Simsek, Said Yasin
    Yasar, Bunyamin
    Pala, Mehmetcan
    Demir, Aysegul
    Atak, Irem Naz
    Mendi, Aysegul Hanife
    Bengi, Vehdi Umut
    Sevel, Guldane Cengiz
    Altuntas, Evrim Gunes
    Kilic, Pelin
    Demir-Dora, Devrim
    CYTOKINE & GROWTH FACTOR REVIEWS, 2022, 63 : 10 - 22
  • [9] Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
    Ahmad, Liyana
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
    Lazarevic, Ivana
    Pravica, Vera
    Miljanovic, Danijela
    Cupic, Maja
    VIRUSES-BASEL, 2021, 13 (07):